Cortexyme, Inc. announced two key leadership appointments. Veteran clinical development professional Michael Detke, M.D., Ph.D., has been appointed Chief Medical Officer and Chris Lowe, a longtime life sciences finance expert, is now the company's Chief Financial Officer. As Chief Medical Officer, Michael Detke will oversee its clinical development and regulatory affairs.

As Chief Financial Officer, Chris Lowe will have responsibility for its finance and investor relations functions, including strategic planning, fundraising, and financial reporting.